Polaprezinc in patients with ulcerative colitis

Trial Profile

Polaprezinc in patients with ulcerative colitis

Phase of Trial: Phase II

Latest Information Update: 01 Feb 2014

At a glance

  • Drugs Polaprezinc (Primary)
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Sep 2012 Data incorporated from University Hospital Information Network Japan (UMIN000008967).
    • 29 May 2012 New trial record
    • 22 May 2012 Results presented at Digestive Disease Week 2012.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top